EP4132299A1 - Vitality dietary supplement - Google Patents

Vitality dietary supplement

Info

Publication number
EP4132299A1
EP4132299A1 EP21716684.2A EP21716684A EP4132299A1 EP 4132299 A1 EP4132299 A1 EP 4132299A1 EP 21716684 A EP21716684 A EP 21716684A EP 4132299 A1 EP4132299 A1 EP 4132299A1
Authority
EP
European Patent Office
Prior art keywords
composition
amount
weight percent
dietary supplement
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP21716684.2A
Other languages
German (de)
French (fr)
Other versions
EP4132299B1 (en
Inventor
Kurt Seidensticker
Katie COTE
Cristina CUTRI
Corey Friese
Luis Vargas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of EP4132299A1 publication Critical patent/EP4132299A1/en
Application granted granted Critical
Publication of EP4132299B1 publication Critical patent/EP4132299B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28—Substances of animal origin, e.g. gelatin or collagen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres

Definitions

  • the present invention is directed to improving immune function by improving or increasing the function of immune cells, promoting adequate hydration, and supplying essential nutrients and amino acids that the immune system requires to function.
  • the supplement composition of the present invention comprises: Collagen Peptides, l-glutamine, l-arginine, Baker’s Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus plantarum, vitamins, and minerals. Immune system function is improved using this combination of components.
  • dietary supplement ingredients have inherit properties that support these immune functions including: Sodium, Potassium, Magnesium, Vitamin C, Vitamin D, Zinc, Collagen, l-glutamine, l-arginine, l-tryptophan, Wellmune® Baker’s Yeast Beta Glucan, lmmuno-LP20R® (Heat-Killed Lacto-bacillus Plantarum L-137).
  • Sodium, Potassium, Magnesium, Vitamin C, Vitamin D, Zinc, Collagen, l-glutamine, l-arginine, l-tryptophan Wellmune® Baker’s Yeast Beta Glucan, lmmuno-LP20R® (Heat-Killed Lacto-bacillus Plantarum L-137).
  • the present invention resolves this deficiency and enhances the uptake of these ingredients and helps support immune function.
  • the present invention is directed to a dietary supplement composition
  • a dietary supplement composition comprising collagen peptides, l-glutamine, l-arginine, Baker’s Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus Plantarum, vitamins, and minerals.
  • the collagen peptides are present in an amount of about 7 to 69 weight percent of the composition
  • l-glutamine is present in an amount of about 3 to about 31 weight percent of the composition
  • l-arginine is present in an amount of about 0.7 to about 8 weight percent of the composition
  • Baker’s Yeast Beta Glucan is present in an amount of about 0.3 to about 4 weight percent of the composition
  • l-tryptophan is present in an amount of about 0.1 to about 0.8 weight percent of the composition
  • Heat-Killed Lactobacillus Plantarum L-137 is present in an amount of about 0.1 to about 0.8 weight percent of the composition.
  • compositions of the present invention are intended to support and enhance immune system function.
  • the present invention relates to a dietary supplement composition that may be consumed as a supplement to support and enhance immune system function
  • compositions of the present invention comprise collagen, preferably in the form of hydrolyzed collagen peptides, in combination with l-glutamine, l-arginine, Baker’s Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus Plantarum, optionally, additional vitamins and minerals.
  • composition may be administered in the form of a liquid, solution, suspension, powder, or gel. If in powder form, the powder is mixed in a soluble liquid prior to administration as directed.
  • Collagen is present in the composition in an amount of about 7 to 69 weight percent of the composition, about 20 to 54 weight percent of the composition, or about 27 to 46 weight percent of the composition.
  • collagen may be present in the composition in an amount of about 1-9 grams/serving, about 3-7 grams/serving, or about 4-6 grams/serving.
  • collagen may be present in the composition in an amount of about 5 grams/serving.
  • Collagen is a protein and may be present in any available form in the composition.
  • the present invention preferably uses collagen peptides.
  • Collagen peptides may be sourced from any known source, including but not limited to, beef, chicken, fish, eggshell membrane, and chicken egg whites.
  • L-glutamine is present in the composition in an amount of about 0.5-4.0 g/serving, about 1-3 g/serving, about 1.5-2.5 g/serving, or about 2 g/serving.
  • l-glutamine may be present in the composition in an amount of about 3-31 weight percent, about 7-23 weight percent, or about 10-19 weight percent.
  • L-arginine is also present in the composition in an amount of about 0.1-1 g/serving, about 0.25- 0.75 g/serving, about 0.4-0.6 g/serving, or about 0.5 g/serving.
  • l-arginine may be present in the composition in an amount of about 0.7-8 weight percent, about 2-6 weight percent, or about 3-5 weight percent.
  • Baker’s Yeast Beta Glucan is also present in the composition in an amount of about 0.05-0.5 g/serving, about 0.15-0.4 g/serving, about 0.2-0.3 g/serving, or about 0.25 g/serving.
  • Baker’s Yeast Beta Glucan may be present in the composition in an amount of about 0.3-4.0 weight percent, about 1-3.1 weight percent, or about 1.3-2 weight percent.
  • Wellmune® Baker’s Yeast Beta Glucan is used.
  • L-tryptophan is also present in the composition in an amount of about 0.01-0.1 g/serving, about 0.025-0.075 g/serving, about 0.04-0.06 g/serving, or about 0.05 g/serving.
  • I- tryptophan may be present in the composition in an amount of about 0.1 -0.8 weight percent, about 0.2-0.6 weight percent, or about 0.3-0.5 weight percent.
  • Heat-Killed Lactobacillus Plantarum L-137 is also present in the composition in an amount of about 0.01-0.1 g/serving, about 0.025-0.075 g/serving, about 0.04-0.06 g/serving, or about 0.05 g/serving.
  • Heat-Killed Lactobacillus Plantarum L-137 may be present in the composition in an amount of about 0.1 -0.8 weight percent, about 0.2-0.6 weight percent, or about 0.3-0.5 weight percent.
  • lmmuno-LP20® Heat-Killed Lactobacillus Plantarum L-137) is used. Additional nutrients may be used in the composition including electrolytes, vitamins, minerals, and other dietary supplements.
  • Suitable electrolyte minerals include, but are not limited to calcium, sodium, potassium, magnesium, calcium, bicarbonate, chloride, zinc and phosphate.
  • the total amount of electrolyte minerals may be added to the composition in an amount of about 7-39 weight percent of the composition, about 10-23, or about 15-21 weight percent of the composition.
  • the total electrolytes may be present in a range of about 1-5 grams/serving, about 1.5-3 grams/serving, or about 2.25-2.75 grams/serving.
  • Sodium may be present in any form, such as sea salt, iodized salt, sodium bicarbonate, or Himalayan pink sea salt, in an amount of about 0.2-1 grams/serving or 0.3-0.7 grams/serving, or about 1.3-8 weight percent or about 2-6 weight percent of the total composition.
  • Potassium may be present in any suitable form, such as a potassium citrate, potassium chloride, potassium sorbate, or the like. Potassium may be present in an amount of about 0.1-2 grams/serving or about 0.2-1 grams/serving, or about 0.7-15 or about 1.3-8 weight percent of the total composition.
  • Magnesium may be present in any suitable form, such as a magnesium citrate, magnesium oxide, magnesium lysinate-glycinate chelate, or magnesium malate. Magnesium may be present in an amount of about 0.01-0.2 grams/serving or about 0.02-0.1 grams/serving, or about 0.1 -1.5 or about 0.1 -0.8 weight percent of the total composition.
  • Zinc may be present in any suitable form, such as a zinc sulfate or zinc citrate. Zinc may be present in an amount of about 0.01-0.2 grams/serving or about 0.01-0.1 grams/serving, or about 0.1 -1.5 or about 0.1 -0.8 weight percent of the total composition.
  • Vitamins may further be added to the composition. Any vitamins suitable for ingestion in a dietary supplement is suitable for use. Suitable vitamins include but are not limited to Vitamin B, including Vitamin B1 (e.g., as thiamine chloride), Vitamin B2 (e.g., as riboflavin), Vitamin B3 (e.g., niacinamide), Vitamin B6 (e.g., as pyridoxine HCI), Vitamin B5 (e.g., as pantothenic acid or D-calcium pantothenate), Vitamin B12 (cyanocobalamin), folate (e.g., as folic acid), Vitamin C (e.g., as sodium ascorbate), Vitamin D, Vitamin E, etc.
  • Vitamin B1 e.g., as thiamine chloride
  • Vitamin B2 e.g., as riboflavin
  • Vitamin B3 e.g., niacinamide
  • Vitamin B6 e.g., as pyridoxine HCI
  • Vitamin B5
  • each of the vitamins may be independently present in the composition in an amount of about 0.01-2 grams/serving, about 0.5-1 .5 grams/serving, about 0.75-1.25 grams/serving, or about 0.001-15.4, about 3-12, or about 5-10 weight percent of the total composition.
  • the composition may be flavored using any known natural flavors to enhance the flavor of the composition.
  • other additives suitable for dietary supplements including but not limited to, monk fruit extract, Himalayan pink sea salt, fruit and vegetable juice powder, beta-carotene, citric acid, and malic acid
  • suitable compositions include, but are not limited, to those described in Table 1.
  • the caloric intake of the supplement is less than about 100 calories, less than about 75 calories, or about 30 calories per serving.
  • the amount of carbohydrates and total sugars in the composition is desirably low.
  • the carbohydrates may be present in an amount of less than 10 grams/serving, less than 7 grams/serving, less than 5 grams/serving, about 2 grams/serving, or about 1 grams/serving.
  • the total sugars is desirably kept low, e.g., less than 6 grams/serving, less than 5 grams/serving, or about 0 gram/serving.
  • the content of the protein, in the form of collagen or collagen peptides is high, preferably above 2 grams/serving, above 4 gram/serving, or about 5 grams/serving.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is directed to improving immune function by improving or increasing the function of immune cells, promoting adequate hydration, and supplying essential nutrients and amino acids that the immune system requires to function. The supplement composition of the present invention comprises: Collagen Peptides, l-glutamine, l-arginine, Baker's Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus plantarum, vitamins, and minerals. Immune system function is improved using this combination of components.

Description

VITALITY DIETARY SUPPLEMENT
FIELD OF THE INVENTION
The present invention is directed to improving immune function by improving or increasing the function of immune cells, promoting adequate hydration, and supplying essential nutrients and amino acids that the immune system requires to function. The supplement composition of the present invention comprises: Collagen Peptides, l-glutamine, l-arginine, Baker’s Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus plantarum, vitamins, and minerals. Immune system function is improved using this combination of components.
BACKGROUND OF THE INVENTION
Every day, thousands of people succumb to the common cold, flu, or other contagious illnesses such as Coronavirus disease (COVID). Many people choose to supplement their diet with functional foods or dietary supplements in order to help bolster their immune system and put themselves in a better position to ward off these illnesses. The ingestion of capsules, tablets, nutritional beverages, or drink powder mixes has been a preferred method to help promote these immune-supporting functions, either by taking daily or immediately before and during the onset of symptoms.
While adequate nutrition, sleep, and practicing good hygiene such as washing hands or avoiding highly congested areas of human traffic are the front lines of defense in supporting the immune system and avoiding a contagious illness, certain ingestible dietary supplements and ingredients have the potential to enhance and improve the function of the immune system and provide the body the support it needs to fight off illness. These parameters can include improving or increasing the function of immune cells, promoting adequate hydration, and supplying essential nutrients and amino acids that the immune system requires to function.
Research has shown that several dietary supplement ingredients have inherit properties that support these immune functions including: Sodium, Potassium, Magnesium, Vitamin C, Vitamin D, Zinc, Collagen, l-glutamine, l-arginine, l-tryptophan, Wellmune® Baker’s Yeast Beta Glucan, lmmuno-LP20R® (Heat-Killed Lacto-bacillus Plantarum L-137). There remains a need to improve immune function by providing essential vitamins and minerals, amino acids, and immune-enhancing specialty ingredients. The present invention resolves this deficiency and enhances the uptake of these ingredients and helps support immune function.
SUMMARY OF THE INVENTION
The present invention is directed to a dietary supplement composition comprising collagen peptides, l-glutamine, l-arginine, Baker’s Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus Plantarum, vitamins, and minerals.
In one embodiment, the collagen peptides are present in an amount of about 7 to 69 weight percent of the composition, l-glutamine is present in an amount of about 3 to about 31 weight percent of the composition, l-arginine is present in an amount of about 0.7 to about 8 weight percent of the composition, Baker’s Yeast Beta Glucan is present in an amount of about 0.3 to about 4 weight percent of the composition, l-tryptophan is present in an amount of about 0.1 to about 0.8 weight percent of the composition, and Heat-Killed Lactobacillus Plantarum L-137 is present in an amount of about 0.1 to about 0.8 weight percent of the composition.
The compositions of the present invention are intended to support and enhance immune system function.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a dietary supplement composition that may be consumed as a supplement to support and enhance immune system function
The compositions of the present invention comprise collagen, preferably in the form of hydrolyzed collagen peptides, in combination with l-glutamine, l-arginine, Baker’s Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus Plantarum, optionally, additional vitamins and minerals.
The composition may be administered in the form of a liquid, solution, suspension, powder, or gel. If in powder form, the powder is mixed in a soluble liquid prior to administration as directed.
Collagen is present in the composition in an amount of about 7 to 69 weight percent of the composition, about 20 to 54 weight percent of the composition, or about 27 to 46 weight percent of the composition. Alternatively, collagen may be present in the composition in an amount of about 1-9 grams/serving, about 3-7 grams/serving, or about 4-6 grams/serving. In a preferred embodiment, collagen may be present in the composition in an amount of about 5 grams/serving. Collagen is a protein and may be present in any available form in the composition. However, the present invention preferably uses collagen peptides. Collagen peptides may be sourced from any known source, including but not limited to, beef, chicken, fish, eggshell membrane, and chicken egg whites.
L-glutamine is present in the composition in an amount of about 0.5-4.0 g/serving, about 1-3 g/serving, about 1.5-2.5 g/serving, or about 2 g/serving. Alternatively, l-glutamine may be present in the composition in an amount of about 3-31 weight percent, about 7-23 weight percent, or about 10-19 weight percent.
L-arginine is also present in the composition in an amount of about 0.1-1 g/serving, about 0.25- 0.75 g/serving, about 0.4-0.6 g/serving, or about 0.5 g/serving. Alternatively, l-arginine may be present in the composition in an amount of about 0.7-8 weight percent, about 2-6 weight percent, or about 3-5 weight percent.
Baker’s Yeast Beta Glucan is also present in the composition in an amount of about 0.05-0.5 g/serving, about 0.15-0.4 g/serving, about 0.2-0.3 g/serving, or about 0.25 g/serving. Alternatively, Baker’s Yeast Beta Glucan may be present in the composition in an amount of about 0.3-4.0 weight percent, about 1-3.1 weight percent, or about 1.3-2 weight percent. In a preferred embodiment, Wellmune® Baker’s Yeast Beta Glucan is used.
L-tryptophan is also present in the composition in an amount of about 0.01-0.1 g/serving, about 0.025-0.075 g/serving, about 0.04-0.06 g/serving, or about 0.05 g/serving. Alternatively, I- tryptophan may be present in the composition in an amount of about 0.1 -0.8 weight percent, about 0.2-0.6 weight percent, or about 0.3-0.5 weight percent.
Heat-Killed Lactobacillus Plantarum L-137 is also present in the composition in an amount of about 0.01-0.1 g/serving, about 0.025-0.075 g/serving, about 0.04-0.06 g/serving, or about 0.05 g/serving. Alternatively, Heat-Killed Lactobacillus Plantarum L-137 may be present in the composition in an amount of about 0.1 -0.8 weight percent, about 0.2-0.6 weight percent, or about 0.3-0.5 weight percent. In a preferred embodiment, lmmuno-LP20® (Heat-Killed Lactobacillus Plantarum L-137) is used. Additional nutrients may be used in the composition including electrolytes, vitamins, minerals, and other dietary supplements. Suitable electrolyte minerals include, but are not limited to calcium, sodium, potassium, magnesium, calcium, bicarbonate, chloride, zinc and phosphate. The total amount of electrolyte minerals may be added to the composition in an amount of about 7-39 weight percent of the composition, about 10-23, or about 15-21 weight percent of the composition. Alternatively, the total electrolytes may be present in a range of about 1-5 grams/serving, about 1.5-3 grams/serving, or about 2.25-2.75 grams/serving.
Sodium may be present in any form, such as sea salt, iodized salt, sodium bicarbonate, or Himalayan pink sea salt, in an amount of about 0.2-1 grams/serving or 0.3-0.7 grams/serving, or about 1.3-8 weight percent or about 2-6 weight percent of the total composition.
Potassium may be present in any suitable form, such as a potassium citrate, potassium chloride, potassium sorbate, or the like. Potassium may be present in an amount of about 0.1-2 grams/serving or about 0.2-1 grams/serving, or about 0.7-15 or about 1.3-8 weight percent of the total composition.
Magnesium may be present in any suitable form, such as a magnesium citrate, magnesium oxide, magnesium lysinate-glycinate chelate, or magnesium malate. Magnesium may be present in an amount of about 0.01-0.2 grams/serving or about 0.02-0.1 grams/serving, or about 0.1 -1.5 or about 0.1 -0.8 weight percent of the total composition.
Zinc may be present in any suitable form, such as a zinc sulfate or zinc citrate. Zinc may be present in an amount of about 0.01-0.2 grams/serving or about 0.01-0.1 grams/serving, or about 0.1 -1.5 or about 0.1 -0.8 weight percent of the total composition.
Vitamins may further be added to the composition. Any vitamins suitable for ingestion in a dietary supplement is suitable for use. Suitable vitamins include but are not limited to Vitamin B, including Vitamin B1 (e.g., as thiamine chloride), Vitamin B2 (e.g., as riboflavin), Vitamin B3 (e.g., niacinamide), Vitamin B6 (e.g., as pyridoxine HCI), Vitamin B5 (e.g., as pantothenic acid or D-calcium pantothenate), Vitamin B12 (cyanocobalamin), folate (e.g., as folic acid), Vitamin C (e.g., as sodium ascorbate), Vitamin D, Vitamin E, etc. In the context of the present invention, each of the vitamins may be independently present in the composition in an amount of about 0.01-2 grams/serving, about 0.5-1 .5 grams/serving, about 0.75-1.25 grams/serving, or about 0.001-15.4, about 3-12, or about 5-10 weight percent of the total composition. Moreover, the composition may be flavored using any known natural flavors to enhance the flavor of the composition. Additionally, other additives suitable for dietary supplements, including but not limited to, monk fruit extract, Himalayan pink sea salt, fruit and vegetable juice powder, beta-carotene, citric acid, and malic acid
In accordance with the present invention, suitable compositions include, but are not limited, to those described in Table 1.
TABLE 1
**Daily Value Not Established
In an embodiment of the present invention, the caloric intake of the supplement is less than about 100 calories, less than about 75 calories, or about 30 calories per serving. Additionally, the amount of carbohydrates and total sugars in the composition is desirably low. For example, the carbohydrates may be present in an amount of less than 10 grams/serving, less than 7 grams/serving, less than 5 grams/serving, about 2 grams/serving, or about 1 grams/serving. Similarly, the total sugars is desirably kept low, e.g., less than 6 grams/serving, less than 5 grams/serving, or about 0 gram/serving. As noted above, the content of the protein, in the form of collagen or collagen peptides, is high, preferably above 2 grams/serving, above 4 gram/serving, or about 5 grams/serving.
EXAMPLE 1
A composition of the formula depicted in Table 1 was prepared.

Claims

Claims
1. A dietary supplement composition comprising collagen in an amount of about 7 to 69 weight percent of the composition, l-glutamine in an amount of about 3 to 31 weight percent of the combination, l-arginine in an amount of about 0.7 to 8 weight percent of the composition, Baker’s Yeast Beta Glucan in an amount of about 0.3 to 4.0 weight percent of the composition, l-tryptophan in an amount of about 0.1 to 0.8 weight percent of the composition, and Heat-Killed Lactobacillus Plantarum L-137 in an amount of about 0.1 to 0.8 weight percent of the composition.
2. The dietary supplement composition of claim 1 , wherein the collagen is present in the form of hydrolyzed collagen peptides.
3. The dietary supplement composition of claim 1 or 2, wherein the composition further comprises electrolyte minerals and wherein total amount of electrolyte minerals is present in an amount of about 7 to 39 weight percent of the total composition.
4. The dietary supplement composition of claim 1 or 2, wherein the composition further comprises vitamins suitable for ingestion in a dietary supplement and wherein each such vitamin is present in an amount of about 0.001-15.4 weight percent of the total composition.
5. The dietary supplement composition according to any one of claims 1 to 4, wherein the composition is a powder.
6. The dietary supplement composition according to any one of claims 1 to 4, wherein the composition is a liquid.
7. The dietary supplement composition of claim 1 , wherein collagen is present in an amount of about 20 to 54 weight percent of the composition, l-glutamine in an amount of about 7 to 23 weight percent of the combination, l-arginine in an amount of about 2 to 6 weight percent of the composition, Baker’s Yeast Beta Glucan in an amount of about 1 to 3.1 weight percent of the composition, l-tryptophan in an amount of about 0.2 to 0.6 weight percent of the composition, and Heat-Killed Lactobacillus Plantarum L-137 in an amount of about 0.2 to 0.6 weight percent of the composition.
8. The dietary supplement composition of claim 7, wherein the collagen is present in the form of hydrolyzed collagen peptides.
9. The dietary supplement composition of claim 7 or 8, wherein the composition further comprises electrolyte minerals and wherein total amount of electrolyte minerals is present in an amount of about 10 to 23 weight percent of the total composition.
10. The dietary supplement composition of claim 7 or 8, wherein the composition further comprises vitamins suitable for ingestion in a dietary supplement and wherein each such vitamin is present in an amount of about 3-12 weight percent of the total composition.
11 . The dietary supplement composition of any one of claims 7 to 10, wherein the composition is a powder.
12. The dietary supplement composition of any one of claims 7 to 10, wherein the composition is a liquid.
13. The dietary supplement composition of claim 1 , wherein collagen is present in an amount of about 27 to 46 weight percent of the composition, l-glutamine in an amount of about 10 to 19 weight percent of the combination, l-arginine in an amount of about 3 to 5 weight percent of the composition, Baker’s Yeast Beta Glucan in an amount of about 1.3 to 2 weight percent of the composition, l-tryptophan in an amount of about 0.3 to 0.5 weight percent of the composition, and (Heat-Killed Lactobacillus Plantarum L-137) in an amount of about 0.3 to 0.5 weight percent of the composition.
14. The dietary supplement composition of claim 13, wherein the collagen is present in the form of hydrolyzed collagen peptides.
15. The dietary supplement composition of claims 13 or 14, wherein the composition further comprises electrolyte minerals and wherein total amount of electrolyte minerals is present in an amount of about 15 to 21 weight percent of the total composition.
16. The dietary supplement composition of claims 13 or 14, wherein the composition further comprises vitamins suitable for ingestion in a dietary supplement and wherein each such vitamin is present in an amount of about 5-10 weight percent of the total composition.
17. The dietary supplement composition of any one of claims 13 to 16, wherein the composition is a powder.
18. The dietary supplement composition of any one of claims 13 to 16, wherein the composition is a liquid.
19. A dietary supplement composition comprising the following ingredients:
**Daily Value Not Established
20 A method of improving immune system function comprising administering to a patient in need thereof the composition according to any one of claims 1 to 19.
EP21716684.2A 2020-04-06 2021-04-01 Vitality dietary supplement Active EP4132299B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063005725P 2020-04-06 2020-04-06
PCT/EP2021/058560 WO2021204644A1 (en) 2020-04-06 2021-04-01 Vitality dietary supplement

Publications (2)

Publication Number Publication Date
EP4132299A1 true EP4132299A1 (en) 2023-02-15
EP4132299B1 EP4132299B1 (en) 2025-06-11

Family

ID=75396765

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21716684.2A Active EP4132299B1 (en) 2020-04-06 2021-04-01 Vitality dietary supplement

Country Status (9)

Country Link
US (1) US20230157344A1 (en)
EP (1) EP4132299B1 (en)
JP (1) JP2023519530A (en)
CN (1) CN115279210A (en)
AU (1) AU2021253451A1 (en)
BR (1) BR112022017285A2 (en)
CA (1) CA3168682A1 (en)
ES (1) ES3037991T3 (en)
WO (1) WO2021204644A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024075140A1 (en) * 2022-10-07 2024-04-11 Krutin Kaushik CHATURVEDI Rehydrating composition of electrolytes with postbiotic and zinc
EP4569082A2 (en) 2023-10-09 2025-06-18 Science Power Srl Methods of preparing a postbiotic composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033521T2 (en) * 1989-12-29 2000-08-31 B. Braun Medical Inc., Bethlehem USE OF ARGININE AS AN IMMUNE STIMULATOR
JP4667568B2 (en) * 2000-09-01 2011-04-13 ハウスウェルネスフーズ株式会社 Immune enhancing composition
US20020119928A1 (en) * 2000-10-27 2002-08-29 Mcanalley Bill H. Dietary supplement compositions
JP2002255846A (en) * 2001-02-26 2002-09-11 Sunstar Inc Oral composition
DE10221403A1 (en) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Dietetic and/or pharmaceutical composition based on free aminoacids, vitamins and minerals, having specific aminoacid profile providing good immunostimulant effect
JP2010095465A (en) * 2008-10-16 2010-04-30 House Wellness Foods Kk Immunostimulating composition containing lactic acid bacterium
CN102228176B (en) * 2011-05-19 2013-02-13 北京康比特体育科技股份有限公司 Composition for increasing immunity and preparation method thereof
CA2865124C (en) * 2012-02-22 2020-07-14 Algal Scientific Corporation Animal feed compositions and methods of using the same
US20160192689A1 (en) * 2013-07-31 2016-07-07 Wikifoods, Inc. Encapsulated functional food compositions
CN108853486B (en) * 2018-05-04 2022-03-04 湖北和格复合骨胶原生物科技有限公司 Formula product with function of enhancing immunity
CN108785660A (en) * 2018-06-21 2018-11-13 石丰 It is a kind of that there are the ox bone collagen protein peptides and preparation method thereof for improving immunity
CN109221864A (en) * 2018-08-28 2019-01-18 杭州千岛湖标普健康食品有限公司 A kind of functional solid beverage and preparation method thereof that the multicomponent enhanced human immunity is compound
CN110468175A (en) * 2019-08-22 2019-11-19 赵秋萍 A kind of composite plant Gly-His-Lys and its preparation method and application

Also Published As

Publication number Publication date
US20230157344A1 (en) 2023-05-25
EP4132299B1 (en) 2025-06-11
AU2021253451A1 (en) 2022-09-08
CA3168682A1 (en) 2021-10-14
ES3037991T3 (en) 2025-10-08
JP2023519530A (en) 2023-05-11
BR112022017285A2 (en) 2022-11-29
WO2021204644A1 (en) 2021-10-14
CN115279210A (en) 2022-11-01

Similar Documents

Publication Publication Date Title
CN101061860B (en) Leucine-rich nutritional compositions
US7790209B2 (en) Total enteral nutritious composition
JP2001120227A (en) Diet food
RU2428062C2 (en) Composition for functional beverage
CN101569410A (en) Special meal nutritional foods used by tumor patients
EP4132299B1 (en) Vitality dietary supplement
JP2002065212A (en) Food composition for strengthening muscle, and muscle- strengthening agent
CN117859892A (en) A gel-like complete nutritional special medical food formula based on animal and plant dual proteins and its preparation method
CN108719977A (en) A kind of breast cancer nutraceutical and preparation method thereof
CA2711862C (en) Composition for improving nutritional status of the elderly, reducing frequency of fever of the elderly and/or increasing immunocompetence of the elderly
CN102273581A (en) Compound sweetener with high sweetness
CN108095075A (en) Miscarriage women tailored version clinical nutrition formula and preparation method thereof
CN103478718B (en) Functional food for improving glutathione concentration in human body and preparation method thereof
Patil et al. Effect of inhibitors on flour fortification: a nutritional approach
JP2002142720A (en) Nutrition composition
HK40082799A (en) Vitality dietary supplement
CN107889889A (en) A kind of formula for the Astaxanthin In Haematococcus Pluvialis milk powder for contributing to recovery of parturient
CN113455595A (en) Production method of chicken with moon meat suitable for nutritional requirements of pregnant and lying-in women
CN113678897A (en) Formula milk powder for promoting nutrient absorption of pregnant and lying-in women and preparation method thereof
EP4099839A1 (en) Dietary supplement composition comprising collagen
RU2817886C1 (en) Dry beverage concentrate for bone tissue recovery
CN111328949A (en) B-vitamin composition solid beverage
CN108378377A (en) The preparation method and applications of cervical carcinoma full nutrition formula food
JP2005224150A (en) Food for preventing overeating
KR20160075431A (en) Composition of balanced nutrition for improving frailty and geriatric syndrome and method for preparing the same

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20221107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230527

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240620

17Q First examination report despatched

Effective date: 20240626

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20250314

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602021032106

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 3037991

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20251008

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250911

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250912

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250911

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251013

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602021032106

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250611

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: CH

Ref legal event code: L10

Free format text: ST27 STATUS EVENT CODE: U-0-0-L10-L00 (AS PROVIDED BY THE NATIONAL OFFICE)

Effective date: 20260423